Higher body mass index (BMI) has been associated with a higher risk for severe COVID-19 outcomes. The aim of this study was to investigate associations among BMI, underlying health conditions and hospital admission as well as the effects of COVID-19 vaccines in adults aged 50 years and older in Europe using data from the Survey of Health, Ageing and Retirement in Europe (SHARE) which was collected from June to August 2021, shortly after the second wave of the COVID-19 pandemic occurred in Europe. Survey data totalling 1936 individuals were used for statistical analyses to calculate the likelihood of hospitalization due to COVID-19 infection in relation to BMI, sociodemographic factors, comorbidities and COVID vaccination status. Approximately 16% of individuals testing positive for COVID-19 were hospitalized for COVID-19, and over 75% of these hospitalized individuals were either overweight or obese. The likelihood of hospitalization for individuals with obesity was approximately 1.5 times (CI [1.05-2.05]) higher than those with a healthy weight (BMI = 18.5-24.9 kg/m2) after adjusting for BMI, sex and age. After adjusting for sociodemographic factors, vaccination and comorbidities, the likelihood of hospitalization for individuals with obesity was 1.34 times higher than those with a healthy weight (CI [0.94-1.90]). Vaccine uptake was lowest in individuals with obesity (BMI ≥ 30 kg/m2) in all age groups. Individuals who had not received a vaccine were 1.8 times more likely to be hospitalized (CI [1.34-2.30]). Across European regions, obesity is associated with higher odds of hospitalization, and vaccination may be effective to reduce these odds for older adults.

Research Centre on Health Quality of Life and Lifestyle in a Geodemographic and Socioeconomic Context Department of Social Geography and Regional Development Faculty of Science Charles University Albertov 6 128 43 Prague Czech Republic

See more in PubMed

Dai H., Alsalhe T.A., Chalghaf N., Riccò M., Bragazzi N.L., Wu J. The Global Burden of Disease Attributable to High Body Mass Index in 195 Countries and Territories, 1990–2017: An Analysis of the Global Burden of Disease Study. PLoS Med. 2020;17:e1003198. doi: 10.1371/journal.pmed.1003198. PubMed DOI PMC

World Health Organization . WHO European Regional Obesity Report 2022. World Health Organization; Copenhagen, Denmark: 2022.

OECD. WHO . Health at a Glance: Asia/Pacific 2020. OECD; Paris, France: 2020.

Eurostat Body Mass Index (BMI) by Sex, Age and Educational Attainment Level. [(accessed on 21 July 2022)]. Available online: https://ec.europa.eu/eurostat/databrowser/view/HLTH_EHIS_BM1E__custom_3099913/default/table?lang=en.

Cercato C., Fonseca F.A. Cardiovascular Risk and Obesity. Diabetol. Metab. Syndr. 2019;11:1–15. doi: 10.1186/s13098-019-0468-0. PubMed DOI PMC

Powell-Wiley T.M., Paul Poirier C., Chair Lora Burke V.E., Jean-Pierre Després F., Penny Gordon-Larsen F., Carl Lavie F.J., Lear S.A., Chiadi Ndumele F.E., Ian Neeland F.J., Prashanthan Sanders F., et al. Aha Scientific Statement: Obesity and Cardiovascular Disease, A Scientific Statement From the American Heart Association. Circulation. 2021;143:e984–e1010. doi: 10.1161/CIR.0000000000000973. PubMed DOI PMC

Renehan A.G., Tyson M., Egger M., Heller R.F., Zwahlen M. Body-Mass Index and Incidence of Cancer: A Systematic Review and Meta-Analysis of Prospective Observational Studies. Lancet. 2008;371:569–578. doi: 10.1016/S0140-6736(08)60269-X. PubMed DOI

Guh D.P., Zhang W., Bansback N., Amarsi Z., Birmingham C.L., Anis A.H. The Incidence of Co-Morbidities Related to Obesity and Overweight: A Systematic Review and Meta-Analysis. BMC Public Health. 2009;9:1–20. doi: 10.1186/1471-2458-9-88. PubMed DOI PMC

Sharma V., Coleman S., Nixon J., Sharples L., Hamilton-Shield J., Rutter H., Bryant M. A Systematic Review and Meta-Analysis Estimating the Population Prevalence of Comorbidities in Children and Adolescents Aged 5 to 18 Years. Obes. Rev. 2019;20:1341–1349. doi: 10.1111/obr.12904. PubMed DOI PMC

O’Donnell D.E., Ciavaglia C.E., Neder J.A. When Obesity and Chronic Obstructive Pulmonary Disease Collide: Physiological and Clinical Consequences. Ann. Am. Thorac. Soc. 2014;11:635–644. doi: 10.1513/AnnalsATS.201312-438FR. PubMed DOI

Garg S., Kim L., Whitaker M., O’Halloran A., Cummings C., Holstein R., Prill M., Chai S.J., Kirley P.D., Alden N.B., et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019—COVID-NET, 14 States, March 1–30, 2020. Morb. Mortal. Wkly. Rep. 2020;69:458. doi: 10.15585/mmwr.mm6915e3. PubMed DOI PMC

Rottoli M., Bernante P., Belvedere A., Balsamo F., Garelli S., Giannella M., Cascavilla A., Tedeschi S., Ianniruberto S., del Turco E.R., et al. How Important Is Obesity as a Risk Factor for Respiratory Failure, Intensive Care Admission and Death in Hospitalised COVID-19 Patients? Results from a Single Italian Centre. Eur. J. Endocrinol. 2020;183:389–397. doi: 10.1530/EJE-20-0541. PubMed DOI PMC

Kompaniyets L., Goodman A.B., Belay B., Freedman D.S., Sucosky M.S., Lange S.J., Gundlapalli A.V., Boehmer T.K., Blanck H.M. Body Mass Index and Risk for COVID-19-Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death—United States, March-December 2020. MMWR Morb. Mortal Wkly. Rep. 2021;70:355–361. doi: 10.15585/mmwr.mm7010e4. PubMed DOI PMC

Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W., Barnaby D.P., Becker L.B., Chelico J.D., Cohen S.L., et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323:2052–2059. doi: 10.1001/jama.2020.6775. PubMed DOI PMC

Honce R., Schultz-Cherry S. Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution. Front. Immunol. 2019;10:1071. doi: 10.3389/fimmu.2019.01071. PubMed DOI PMC

Neidich S.D., Green W.D., Rebeles J., Karlsson E.A., Schultz-Cherry S., Noah T.L., Chakladar S., Hudgens M.G., Weir S.S., Beck M.A. Increased Risk of Influenza among Vaccinated Adults Who Are Obese. Int. J. Obes. 2017;41:1324–1330. doi: 10.1038/ijo.2017.131. PubMed DOI PMC

The World Health Organization (WHO) Coronavirus Disease (COVID-19) Pandemic. [(accessed on 21 July 2022)]. Available online: https://www.who.int/europe/emergencies/situations/covid-19.

Wang H., Paulson K.R., Pease S.A., Watson S., Comfort H., Zheng P., Aravkin A.Y., Bisignano C., Barber R.M., Alam T., et al. Estimating Excess Mortality Due to the COVID-19 Pandemic: A Systematic Analysis of COVID-19-Related Mortality, 2020–2021. Lancet. 2022;399:1513–1536. doi: 10.1016/S0140-6736(21)02796-3. PubMed DOI PMC

Thakur B., Dubey P., Benitez J., Torres J.P., Reddy S., Shokar N., Aung K., Mukherjee D., Dwivedi A.K. A Systematic Review and Meta-Analysis of Geographic Differences in Comorbidities and Associated Severity and Mortality among Individuals with COVID-19. Sci. Rep. 2021;11:8562. doi: 10.1038/s41598-021-88130-w. PubMed DOI PMC

IHME COVID-19 Cumulative Deaths. [(accessed on 22 July 2022)]. Available online: https://covid19.healthdata.org/japan?view=cumulative-deaths&tab=compare.

Gao M., Piernas C., Astbury N.M., Hippisley-Cox J., O’Rahilly S., Aveyard P., Jebb S.A. Associations between Body-Mass Index and COVID-19 Severity in 6·9 Million People in England: A Prospective, Community-Based, Cohort Study. Lancet Diabetes Endocrinol. 2021;9:350–359. doi: 10.1016/S2213-8587(21)00089-9. PubMed DOI PMC

Sawadogo W., Tsegaye M., Gizaw A., Adera T. Overweight and Obesity as Risk Factors for COVID-19-Associated Hospitalisations and Death: Systematic Review and Meta-Analysis. BMJ Nutr. Prev. Health. 2022;5:e000375. doi: 10.1136/bmjnph-2021-000375. PubMed DOI PMC

Hamer M., Gale C.R., Kivimäki M., Batty G.D. Overweight, Obesity, and Risk of Hospitalization for COVID-19: A Community-Based Cohort Study of Adults in the United Kingdom. Proc. Natl. Acad. Sci. USA. 2020;117:21011–21013. doi: 10.1073/pnas.2011086117. PubMed DOI PMC

Kloka J.A., Blum L.V., Old O., Zacharowski K., Friedrichson B. Characteristics and Mortality of 561,379 Hospitalized COVID-19 Patients in Germany until December 2021 Based on Real-Life Data. Sci. Rep. 2022;12:11116. doi: 10.1038/s41598-022-15287-3. PubMed DOI PMC

Klang E., Kassim G., Soffer S., Freeman R., Levin M.A., Reich D.L. Severe Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50. Obesity. 2020;28:1595–1599. doi: 10.1002/oby.22913. PubMed DOI PMC

Tartof S.Y., Qian L., Hong V., Wei R., Nadjafi R.F., Fischer H., Li Z., Shaw S.F., Caparosa S.L., Nau C.L., et al. Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization. Ann. Intern. Med. 2020;173:773–781. doi: 10.7326/M20-3742. PubMed DOI PMC

Bonanad C., García-Blas S., Tarazona-Santabalbina F., Sanchis J., Bertomeu-González V., Fácila L., Ariza A., Núñez J., Cordero A. The Effect of Age on Mortality in Patients with COVID-19: A Meta-Analysis with 611,583 Subjects. J. Am. Med. Dir. Assoc. 2020;21:915–918. doi: 10.1016/j.jamda.2020.05.045. PubMed DOI PMC

Hulíková Tesárková K., Dzúrová D. The Age Structure of Cases as the Key of COVID-19 Severity: Longitudinal Population-Based Analysis of European Countries during 150 Days. Scand. J. Public Health. 2021;50:738–747. doi: 10.1177/14034948211042486. PubMed DOI

Imam Z., Odish F., Gill I., O’Connor D., Armstrong J., Vanood A., Ibironke O., Hanna A., Ranski A., Halalau A. Older Age and Comorbidity Are Independent Mortality Predictors in a Large Cohort of 1305 COVID-19 Patients in Michigan, United States. J. Intern. Med. 2020;288:469–476. doi: 10.1111/joim.13119. PubMed DOI PMC

Yanez N.D., Weiss N.S., Romand J.A., Treggiari M.M. COVID-19 Mortality Risk for Older Men and Women. BMC Public Health. 2020;20:1–7. doi: 10.1186/s12889-020-09826-8. PubMed DOI PMC

Börsch-Supan A., Brandt M., Hunkler C., Kneip T., Korbmacher J., Malter F., Schaan B., Stuck S., Zuber S. Data Resource Profile: The Survey of Health, Ageing and Retirement in Europe (Share) Int. J. Epidemiol. 2013;42:992–1001. doi: 10.1093/ije/dyt088. PubMed DOI PMC

Börsch-Supan A. Survey of Health, Ageing and Retirement in Europe (SHARE) Wave 9. COVID-19 Survey 2. Release Version: 8.0.0. SHARE-ERIC. Data Set. 2022. [(accessed on 15 August 2022)]. Available online: http://www.share-project.org/special-data-sets/share-corona-survey-2.html.

Dong E., Du H., Gardner L. An Interactive Web-Based Dashboard to Track COVID-19 in Real Time. Lancet Infect. Dis. 2020;20:533–534. doi: 10.1016/S1473-3099(20)30120-1. PubMed DOI PMC

European Centre for Disease Prevention and Control (ECDC) Overview of COVID-19 Vaccination Strategies and Vaccine Deployment Plans in the EU/EEA and the UK Key Findings. ECDC; Solna, Sweden: 2020.

Dicker D., Bettini S., Farpour-Lambert N., Frühbeck G., Golan R., Goossens G., Halford J., O’malley G., Mullerova D., Ramos Salas X., et al. Position Statement Obesity and COVID-19: The Two Sides of the Coin. Obes. Facts. 2020;13:430–438. doi: 10.1159/000510005. PubMed DOI PMC

Plourde G., Fournier-Ross E., Tessier-Grenier H., Mullie L.A., Chassé M., Carrier F.M. Association between Obesity and Hospital Mortality in Critical COVID-19: A Retrospective Cohort Study. Int. J. Obes. 2021;45:2617–2622. doi: 10.1038/s41366-021-00938-8. PubMed DOI PMC

Biscarini S., Colaneri M., Ludovisi S., Seminari E., Pieri T.C., Valsecchi P., Gallazzi I., Giusti E., Cammà C., Zuccaro V., et al. The Obesity Paradox: Analysis from the SMAtteo COvid-19 REgistry (SMACORE) Cohort. Nutr. Metab. Cardiovasc. Dis. 2020;30:1920–1925. doi: 10.1016/j.numecd.2020.07.047. PubMed DOI PMC

O’hearn M., Liu J., Cudhea F., Micha R., Mozaffarian D. Coronavirus Disease 2019 Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A Comparative Risk Assessment Analysis. J. Am. Heart Assoc. 2021;10:1–27. doi: 10.1161/JAHA.120.019259. PubMed DOI PMC

Piernas C., Patone M., Astbury N.M., Gao M., Dixon MRCGP S., Coupland C., Aveyard FRCGP P., Hippisley-Cox FRCP J., Jebb S.A., Piernas C., et al. Associations of BMI with COVID-19 Vaccine Uptake, Vaccine Effectiveness, and Risk of Severe COVID-19 Outcomes after Vaccination in England: A Population-Based Cohort Study. Lancet Diabetes Endocrinol. 2022;10:571–580. doi: 10.1016/S2213-8587(22)00158-9. PubMed DOI PMC

Yates T., Zaccardi F., Islam N., Razieh C., Gillies C.L., Lawson C.A., Chudasama Y., Rowlands A., Davies M.J., Docherty A.B., et al. Obesity, Chronic Disease, Age, and in-Hospital Mortality in Patients with Covid-19: Analysis of ISARIC Clinical Characterisation Protocol UK Cohort. BMC Infect. Dis. 2021;21:1–9. doi: 10.1186/s12879-021-06466-0. PubMed DOI PMC

Smati S., Tramunt B., Wargny M., Caussy C., Gaborit B., Vatier C., Vergès B., Ancelle D., Amadou C., Bachir L.A., et al. Relationship between Obesity and Severe COVID-19 Outcomes in Patients with Type 2 Diabetes: Results from the CORONADO Study. Diabetes Obes. Metab. 2021;23:391. doi: 10.1111/dom.14228. PubMed DOI PMC

Lindgren M., Toska T., Alex C., Lundberg C.E., Cronie O., Rosengren A., Adiels M., Sjöland H. BMI, Sex and Outcomes in Hospitalised Patients in Western Sweden during the COVID-19 Pandemic. Sci. Rep. 2022;12:1–9. doi: 10.1038/s41598-022-09027-w. PubMed DOI PMC

Popkin B.M., Du S., Green W.D., Beck M.A., Algaith T., Herbst C.H., Alsukait R.F., Alluhidan M., Alazemi N., Shekar M. Individuals with Obesity and COVID-19: A Global Perspective on the Epidemiology and Biological Relationships. Obes. Rev. 2020;21:e13128. doi: 10.1111/obr.13128. PubMed DOI PMC

Pijls B.G., Jolani S., Atherley A., Derckx R.T., Dijkstra J.I.R., Franssen G.H.L., Hendriks S., Richters A., Venemans-Jellema A., Zalpuri S., et al. Demographic Risk Factors for COVID-19 Infection, Severity, ICU Admission and Death: A Meta-Analysis of 59 Studies. BMJ Open. 2021;11:e044640. doi: 10.1136/bmjopen-2020-044640. PubMed DOI PMC

de Heredia F.P., Gómez-Martínez S., Marcos A. Obesity, Inflammation and the Immune System. Proc. Nutr. Soc. 2012;71:332–338. doi: 10.1017/S0029665112000092. PubMed DOI

O’Brien K.B., Vogel P., Duan S., Govorkova E.A., Webby R.J., McCullers J.A., Schultz-Cherry S. Impaired Wound Healing Predisposes Obese Mice to Severe Influenza Virus Infection. J. Infect. Dis. 2012;205:252. doi: 10.1093/infdis/jir729. PubMed DOI PMC

Honce R., Karlsson E.A., Wohlgemuth N., Estrada L.D., Meliopoulos V.A., Yao J., Schultz-Cherry S. Obesity-Related Microenvironment Promotes Emergence of Virulent Influenza Virus Strains. mBio. 2020;11:e03341-19. doi: 10.1128/mBio.03341-19. PubMed DOI PMC

Stefan N. Metabolic Disorders, COVID-19 and Vaccine-Breakthrough Infections. Nat. Rev. Endocrinol. 2021;18:75–76. doi: 10.1038/s41574-021-00608-9. PubMed DOI PMC

Yamamoto S., Mizoue T., Tanaka A., Oshiro Y., Inamura N., Konishi M., Ozeki M., Miyo K., Sugiura W., Sugiyama H., et al. Sex-Associated Differences between BMI and SARS-CoV-2 Antibody Titers Following the BNT162b2 Vaccine. Obesity. 2022;30:999–1003. doi: 10.1002/oby.23417. PubMed DOI PMC

Kizilkaya M.C., Kilic S.S., Oncel D., Mamidanna S., Daliparty V., Yilmaz S., Bozkurt M.A., Sibic O., Sayan M. Barriers to Coronavirus Disease 19 Vaccination in Patients with Obesity. Am. J. Surg. 2022 doi: 10.1016/j.amjsurg.2022.08.021. PubMed DOI PMC

Vallis M., Glazer S. Protecting Individuals Living with Overweight and Obesity: Attitudes and Concerns toward COVID-19 Vaccination in Canada. Obesity. 2021;29:1128–1137. doi: 10.1002/oby.23182. PubMed DOI PMC

Nafilyan V., Dolby T., Razieh C., Gaughan C.H., Morgan J., Ayoubkhani D., Walker S., Khunti K., Glickman M., Yates T. Sociodemographic Inequality in COVID-19 Vaccination Coverage among Elderly Adults in England: A National Linked Data Study. BMJ Open. 2021;11:e053402. doi: 10.1136/bmjopen-2021-053402. PubMed DOI PMC

Valckx S., Crèvecoeur J., Verelst F., Vranckx M., Hendrickx G., Hens N., van Damme P., Pepermans K., Beutels P., Neyens T. Individual Factors Influencing COVID-19 Vaccine Acceptance in between and during Pandemic Waves (July–December 2020) Vaccine. 2022;40:151–161. doi: 10.1016/j.vaccine.2021.10.073. PubMed DOI PMC

Marmot M., Allen J., Goldblatt P., Herd E., Morrison J. Build. Back Fairer: The COVID-19 Marmot Review, The Pandemic, Socioeconomic and Health Inequalities in England. The Health Foundation; London, UK: 2020.

UK Health Security Agency COVID-19 Vaccination Programme—GOV.UK. [(accessed on 1 August 2022)]; Available online: https://www.gov.uk/government/collections/covid-19-vaccination-programme.

Race Disparity Unit. Cabinet Office . Final Report on Progress to Address COVID-19 Health Inequalities—GOV.UK. Race Disparity Unit; London, UK: 2021.

Alban C., Posner X., Fox B., Rubin-Miller L. Pandemic Pound Theories Don’t Hold Weight. Jul 2, 2021. [(accessed on 21 July 2022)]. Available online: https://epicresearch.org/articles/pandemic-pound-theories-dont-hold-weight.

Health inequalities in post-COVID-19 outcomes among adults aged 50+ in Europe: has COVID-19 exposed divide between postcommunist countries and Western Europe?